Accipiter Biosciences Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Accipiter Biosciences Inc. - overview
Established
2023
Location
Seattle, WA-Washington, US
Primary Industry
Biotechnology
About
Based in Washington, US, and founded in 2023 by co-founders Matthew Bick, Javier Castellanos, and Hector Rincon, Accipiter Biosciences operates as a biotechnology company. In July 2026, Accipiter Biosciences Inc. raised USD 10. 5 million in seed funding co-led by Flying Fish and Takeda Digital Ventures, with participation from Columbus Venture Partners, Cercano Management, WRF Capital, Alexandria Venture Investments, Pack Ventures and Argonautic Ventures.
Accipiter Biosciences specializes in the development of next-generation multifunctional biologics, by utilizing advanced computational methods. The company's expertise lies in designing multifunctional biologics that could potentially revolutionize the treatment landscape across various therapeutic areas. The company plans to use the July 2026 funding to accelerate development of additional drug candidates, expand its clinical portfolio, and grow its scientific team.
Current Investors
Alexandria Venture Investments, WRF Capital, Flying Fish
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Healthcare IT, Medical Software, Analytics & Performance Software
Website
www.accipiterbio.com
Verticals
Artificial Intelligence
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Accipiter Biosciences Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Seed | Completed | Accipiter Biosciences Inc. | - | ||||||||
| Seed | Completed | Accipiter Biosciences Inc. | - | ||||||||
| Seed | Completed | Accipiter Biosciences Inc. | - |
Displaying 1 - 3 of 3
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.